Re/Max, UniQure and Trinseo Fall to 52-Week Lows on Exit From S&P SmallCap 600
By Josh Beckerman
Shares of Re/Max Holdings, uniQure and Trinseo fell to 52-week lows Tuesday on news that the stocks will be removed from the S&P SmallCap 600.
Shares of real-estate brokerage franchiser Re/Max were recently down 12% to $14.51, with a low of $13.62 for the day. The 52-week high of $24.28 was set Feb. 2.
UniQure was down 12% to $7.69, with a low of $7.40 Tuesday. The gene therapy company's shares reached a 52-week high of $28.26 on Nov. 29. On Tuesday, the company said the U.S. Food and Drug Administration cleared its investigational new drug application for AMT-260, a gene therapy candidate for refractory mesial temporal lobe epilepsy.
Shares of Trinseo, whose products include plastics and latex binders, were recently down 19% to $8.73. The new 52-week low was $8.04. The 52-week high of $30.54 occurred Feb. 3.
S&P Dow Jones Indices announced a wide range of index changes that will take effect Sept. 18 to coincide with the quarterly rebalance. The changes are intended to make each index more representative of its market capitalization range.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
September 05, 2023 13:44 ET (17:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth